共 58 条
[1]
McGovern M(2006)Natural history of type A Niemann-Pick disease: possible endpoints for therapeutic trials Neurology 66 228-232
[2]
Aron A(2017)Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD) Orphanet J Rare Dis 12 1-13
[3]
Brodie S(2019)Niemann-Pick disease A or B in four pediatric patients and SMPD1 mutation carrier frequency in the Mexican population Ann Hepatol 18 613-619
[4]
Desnick R(2008)A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B Pediatrics 122 398-407
[5]
Wasserstein M(2018)Mucolipidosis type III gamma: three novel mutation and genotype-phenotype study in eleven patients Gene 642 1-7
[6]
McGovern MM(2016)Short communication impact of early enzyme-replacement therapy for mucopolysaccharidosis VI: results of a long-term follow-up of Brazilian siblings Genet Mol Res 15 13-23
[7]
Avetisyan R(2016)Gaucher disease: clinical, biological and therapeutic aspects Pathobiology 83 27-33
[8]
Sanson B-J(2017)Types A and B Niemann-Pick disease Mol Genet Metab 120 126-1550
[9]
Lidove O(2019)Characterization of Niemann-Pick diseases genes mutation spectrum in Iran and identification of a novel mutation in SMPD1 gene Med J Islam Repub Iran 33 1543-838
[10]
Cerón-Rodríguez M(2021)One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency Genet Med 23 829-undefined